- Home
- GDTC vs WVVI Comparison
GDTC vs WVVI Comparison
Compare GDTC & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- WVVI
- Stock Information
- Founded
- GDTC 2018
- WVVI 1983
- Country
- GDTC Singapore
- WVVI United States
- Employees
- GDTC N/A
- WVVI N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- GDTC Health Care
- WVVI Consumer Staples
- Exchange
- GDTC Nasdaq
- WVVI Nasdaq
- Market Cap
- GDTC 28.0M
- WVVI 29.0M
- IPO Year
- GDTC 2023
- WVVI N/A
- Fundamental
- Price
- GDTC $2.40
- WVVI $6.03
- Analyst Decision
- GDTC Buy
- WVVI
- Analyst Count
- GDTC 1
- WVVI 0
- Target Price
- GDTC $5.00
- WVVI N/A
- AVG Volume (30 Days)
- GDTC 32.5K
- WVVI 3.9K
- Earning Date
- GDTC 01-01-0001
- WVVI 05-12-2025
- Dividend Yield
- GDTC N/A
- WVVI N/A
- EPS Growth
- GDTC N/A
- WVVI N/A
- EPS
- GDTC N/A
- WVVI N/A
- Revenue
- GDTC $330,254.00
- WVVI $39,782,442.00
- Revenue This Year
- GDTC $14.71
- WVVI N/A
- Revenue Next Year
- GDTC N/A
- WVVI N/A
- P/E Ratio
- GDTC N/A
- WVVI N/A
- Revenue Growth
- GDTC N/A
- WVVI 1.65
- 52 Week Low
- GDTC $1.20
- WVVI $3.17
- 52 Week High
- GDTC $4.05
- WVVI $6.33
- Technical
- Relative Strength Index (RSI)
- GDTC 48.41
- WVVI 51.90
- Support Level
- GDTC $2.20
- WVVI $5.59
- Resistance Level
- GDTC $2.46
- WVVI $6.15
- Average True Range (ATR)
- GDTC 0.21
- WVVI 0.15
- MACD
- GDTC 0.01
- WVVI 0.00
- Stochastic Oscillator
- GDTC 34.67
- WVVI 66.65
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.